Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0G8KA
|
||||
| Former ID |
DIB020690
|
||||
| Drug Name |
Pfizer compound 11
|
||||
| Drug Type |
Small molecular drug
|
||||
| Formula |
C24H18ClF3N4O3
|
||||
| InChI |
InChI=1S/C24H18ClF3N4O3/c1-15-14-22(32(31-15)20-8-4-2-6-18(20)25)34-21-9-5-3-7-19(21)30-23(33)29-16-10-12-17(13-11-16)35-24(26,27)28/h2-14H,1H3,(H2,29,30,33)
|
||||
| InChIKey |
SAIPZPCGTLOMFE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | P2Y purinoceptor 1 | Target Info | Antagonist | [529445] | |
| References | |||||
| Ref 529445 | Bioorg Med Chem Lett. 2008 Jun 1;18(11):3338-43. Epub 2008 Apr 15.P2Y1 receptor antagonists as novel antithrombotic agents. | ||||
| Ref 541124 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5804). | ||||